4
Participants
Start Date
March 31, 2007
Primary Completion Date
October 31, 2009
Study Completion Date
October 31, 2009
OncoGel (ReGel/Paclitaxel)
OncoGel administered into cavity after surgical resection of recurrent glioma. Each subject will receive one dose of OncoGel on the day of surgical resection.
University of Rochester Medical Center, Rochester
The Johns Hopkins University, Baltimore
University of North Carolina at Chapel Hill, Chapel Hill
Vanderbilt University Medical Center, Nashville
The University of Chicago Brain Tumor Center, Chicago
Lead Sponsor
Boston Scientific Corporation
INDUSTRY